Navigation Links
Advanced Life Sciences Announces US Army Collaboration to Research and Develop Restanza for the Treatment of Malaria
Date:11/2/2010

CHICAGO, Nov. 2, 2010 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that it has entered into a Cooperative Research and Development Agreement ("CRADA") with The Walter Reed Army Institute of Research.  The purpose of this CRADA is to allow The Walter Reed Army Institute of Research to perform advanced animal efficacy testing of Restanza™ (cethromycin), the Company's novel oral antibiotic, against various Plasmodium species that cause malaria.  This CRADA is built on the positive in vitro and in vivo efficacy results that Restanza demonstrated in initial studies with Walter Reed.

(Logo:  http://photos.prnewswire.com/prnh/20080218/ALSLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

"Developing new treatments for malaria is a high-priority for the US military because of malaria's global prevalence, debilitating nature, potential lethality, and tendency to become resistant to current drugs," stated Michael T. Flavin, Ph.D., chief executive officer of Advanced Life Sciences.  "We share the US Army's mission to protecting our troops in the field with novel therapies that can combat infectious diseases such as malaria.  Advanced Life Sciences remains committed to developing Restanza as a new drug to protect public health and we are very pleased to expand our collaboration with the Walter Reed Army Institute of Research toward this goal."

In May 2010, the Company announced that preliminary in vitro and i
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer
2. Advanced Targeting Systems, Inc. Announces $3 Million Award from National Cancer Institute
3. Aeterna Zentaris Announces NIH Grant for a Phase 1/2 Study in Advanced Prostate Cancer with AEZS-108
4. Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax
5. Advanced Life Sciences Expands Antibiotic Pipeline
6. Advanced Life Sciences CEO Acquires $2 Million of Common Stock Through Debt for Equity Exchange
7. Reportlinker Adds Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
8. Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
9. Sermo Announces New Client Center with Advanced Mining and Monitoring of Organic Physician Dialog
10. Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use
11. Advanced Phase I and Phase II Studies of Targeted Gene Delivery Confirm That Rexin-G Impacts Survival in Chemotherapy-resistant Bone and Soft Tissue Sarcoma (ASCO 2010)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision medicine ... to enable the broad use of genomic, imaging and other ... appointment of Michelle Munson , CEO of Aspera, an ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We ...
(Date:12/24/2014)... Texas , Dec. 24, 2014  Vermillion, Inc. ... on gynecologic disease, announced today that the Company ... including Oracle Investment Management, Jack W. Schuler ... Total proceeds were $10.5 million, before offering expenses.  ...
(Date:12/24/2014)... SoundConnect’s 2015 next ... edge communication technology, provide continued education and inform ... series demonstrates online communication features and benefits; empowering ... most innovative and powerful tools. , According to ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3
... Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XTL) today ... regarding the Company,s activities in seeking to acquire potential assets ... XTL. The Company is currently evaluating several merger proposals that ... companies who operate in and outside of the healthcare space. ...
... 23andMe , Inc., an industry leader in ... research company dedicated to the development of treatments for ... in Davos, Switzerland, that they are collaborating to advance ... of the companies to the World Economic Forum, where ...
... dots created by researchers at Canada,s National Institute for ... new level of control over individual electrons, a development ... Composed of a single atom of silicon and measuring ... smallest quantum dots ever created. , Quantum ...
Cached Biology Technology:XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives 223andMe and mondoBIOTECH Partner to Advance Research of Rare Diseases 223andMe and mondoBIOTECH Partner to Advance Research of Rare Diseases 3Smallest ever quantum dots bring real world applications closer 2
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... addition of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... digital media watermarking and fingerprinting markets. Watermarking aims ...
(Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, today announced ... genetic ancestry of individuals from across the United ... than four hundred years ago, the United States ... from different continents. This study illuminates how American history and ...
(Date:12/17/2014)...  HITLAB SM announced today its completion of a ... to current U.S. Food and Drug Administration (FDA) regulations. ... and smart phone application trials utilizing the highest principles ... is determined to improve global healthcare access, quality, and ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... by the Biotechnology and Biological Sciences Research Council and ... have developed a revolutionary way of capturing a high-resolution ... technology that is attractive for science, industry and consumer ... in standard cameras and digital movie projectors they have ...
... Feb. 12, 2010 -- By taking advantage of a ... for electronics designers, a team led by Oak Ridge ... biological sensor with unprecedented sensitivity. Ultimately, researchers believe ... approaches the theoretical limit, surpassing other state-of-the-art chemical sensors. ...
... Haven, Conn.Yale University scientists have streamlined the process for synthesizing ... and other diseased cells, and have found that they represent ... this week,s online edition of the Journal of the ... family of compounds known as the kinamycins, which are naturally ...
Cached Biology News:Cameras of the future: heart researchers create revolutionary photographic technique 2Cameras of the future: heart researchers create revolutionary photographic technique 3Cameras of the future: heart researchers create revolutionary photographic technique 4New ORNL sensor exploits traditional weakness of nano devices 2Scientists synthesize unique family of anti-cancer compounds 2
CHIMAERIC HUMAN IgA2 ANTI NP...
ANTI NO-TRYPTOPHAN CONJUGATE...
... The Captivate magnetic ... can be used in conjunction ... (C-21473, C-21474, C-21476) or other ... with most 96-well microplates. Cell ...
Protein Phosphorylation...
Biology Products: